Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Maxillofacial and Oral Surgery

05.09.2024 | ORIGINAL ARTICLE

Local Single-Dose Teriparatide Administration for BRONJ Prevention: Insights from a Rat Model Study

verfasst von: Milad Etemadi Sh, Farshad Teimoori, MohammadSoroush Sehat, Seyed Mohammad Razavi, Golnaz Tajmiri

Erschienen in: Journal of Maxillofacial and Oral Surgery

Einloggen, um Zugang zu erhalten

Abstract

Background

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) presents significant clinical challenges with uncertain treatment outcomes. Teriparatide, a fragment of human parathyroid hormone, shows potential in prevention strategies for BRONJ.

Objective

This study investigates the impact of a single local dose of teriparatide on BRONJ prevention in an animal model.

Methods

BRONJ was induced on 26 male Wistar rats via intraperitoneal injections of 0.06 mg/kg Zoledronic acid weekly for four weeks. Following tooth extraction under general anesthesia, rats were divided into two groups: one received teriparatide via Gelatamp in the tooth socket and the other as a local injection in the vestibule. Control groups received the treatment without teriparatide. Histopathological assessments for bone remodeling, osteoclast number, inflammation, angiogenesis, and necrosis were performed after four weeks.

Results

Histopathological analysis indicated a significant improvement in bone remodeling and new bone formation in both treatment groups compared to controls, with notably better outcomes in the injection group (p = 0.01). Necrosis in the Gelatamp group was significantly higher in the control group than in the treatment group (p = 0.01), and bone formation was significantly higher in the injection group compared to the Gelatamp group (p = 0.03).

Conclusion

Local administration of teriparatide significantly enhances bone remodeling and reduces necrosis, suggesting a potential role in the prevention of BRONJ. These findings support further clinical investigation into teriparatide as a preventive strategy against BRONJ.
Literatur
1.
Collinge C, Favela J (2016) Use of teriparatide in osteoporotic fracture patients. Injury 47(Suppl 1):S36–S38CrossRefPubMed
2.
Dayisoylu EH, Senel FC, Ungor C, Tosun E, Cankaya M, Ersoz S et al (2013) The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study. Int J Oral Maxillofac Surg 42(11):1475–1480CrossRefPubMed
3.
Kuroshima S, Entezami P, McCauley LK, Yamashita J (2014) Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing. Osteoporos Int 25(3):1141–1150CrossRefPubMed
4.
Jacobson JA, Yanoso-Scholl L, Reynolds DG, Dadali T, Bradica G, Bukata S et al (2011) Teriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defects. Tissue Eng Part A 17(3–4):389–398CrossRefPubMed
5.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B et al (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72(10):1938–1956CrossRefPubMed
6.
Ripamonti CI, Napoli N (2020) Are we ready to use teriparatide to treat medication-related osteonecrosis of the jaw in clinical practice? J Clin Oncol 38(26):2949–2951CrossRefPubMed
7.
Di Fede O, Canepa F, Panzarella V, Mauceri R, Del Gaizo C, Bedogni A et al (2021) The treatment of medication-related osteonecrosis of the jaw (MRONJ): a systematic review with a pooled analysis of only surgery versus combined protocols. Int J Environ Res Public Health 18(16):8432CrossRefPubMedPubMedCentral
8.
Narongroeknawin P, Danila MI, Humphreys LG Jr, Barasch A, Curtis JR (2010) Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist 30(2):77–82CrossRefPubMedPubMedCentral
9.
Kim KM, Park W, Oh SY, Kim HJ, Nam W, Lim SK et al (2014) Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int 25(5):1625–1632CrossRefPubMed
10.
Kim JY, Park JH, Jung HD, Jung YS (2019) Treatment of medication-related osteonecrosis of the jaw around the dental implant with a once-weekly teriparatide: a case report and literature review. J Oral Implantol 45(5):403–407CrossRefPubMed
11.
Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363(25):2473–2474CrossRefPubMed
12.
Ohbayashi Y, Iwasaki A, Nakai F, Mashiba T, Miyake M (2020) A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration. Osteoporos Int 31(3):577–585CrossRefPubMed
13.
Neuprez A, Rompen E, Crielaard JM, Reginster JY (2014) Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient. Calcif Tissue Int 95(1):94–96CrossRefPubMed
14.
Ohbayashi Y, Miyake M, Sawai F, Minami Y, Iwasaki A, Matsui Y (2013) Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 115(4):e31–e37CrossRefPubMed
15.
Yoshiga D, Yamashita Y, Nakamichi I, Tanaka T, Yamauchi K, Yamamoto N et al (2013) Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int 24(8):2365–2369CrossRefPubMedPubMedCentral
16.
Kwon YD, Lee DW, Choi BJ, Lee JW, Kim DY (2012) Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int 23(11):2721–2725CrossRefPubMed
17.
Lee JJ, Cheng SJ, Jeng JH, Chiang CP, Lau HP, Kok SH (2011) Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck 33(9):1366–1371CrossRefPubMed
18.
Sim IW, Borromeo GL, Tsao C, Hardiman R, Hofman MS, Papatziamos Hjelle C et al (2020) Teriparatide promotes bone healing in medication-related osteonecrosis of the jaw: a placebo-controlled. Randomized Trial J Clin Oncol 38(26):2971–2980PubMed
19.
Chopra K, Malhan N (2020) Teriparatide for the treatment of medication-related osteonecrosis of the jaw. Am J Ther 28(4):e469–e477CrossRefPubMed
20.
Dos Santos FL, Abreu LG, Calderipe CB, Martins MD, Schuch LF, Vasconcelos ACU (2021) Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis. Osteoporos Int 32(12):2449–2459CrossRef
21.
Koca CG, Kösehasanoğulları M (2021) Evaluation of single-dose applied teriparatide effect on bone healing with histomorphometric and micro-ct analysis. J Craniomaxillofac Surg 49(2):98–103CrossRefPubMed
22.
Özer T, Başlarlı Ö, Aktaş A, Barış E, Çelik HH, Ocak M (2019) Locally administrated single-dose teriparatide affects critical-size rabbit calvarial defects: a histological, histomorphometric and micro-CT study. Acta Orthop Traumatol Turc 53(6):478–484CrossRefPubMedPubMedCentral
23.
Zandi M, Dehghan A, Malekzadeh H, Janbaz P, Ghadermazi K, Amini P (2016) Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model. J Craniomaxillofac Surg 44(3):271–278CrossRefPubMed
24.
Woo S-B, Hellstein JW, Kalmar JRJ (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144(10):753–761CrossRefPubMed
25.
Etemadi ShM, Hsieh N-C, Movahed Mohammadi SS, Momeni S, Razavi SM, Alizargar J (2020) Histological and radiological evaluation of low-intensity pulsed ultrasound versus whole body vibration on healing of mandibular bone defects in rats. Medicina 56(9):457CrossRef
26.
Aeinehchi M, Eslami B, Ghanbariha M, Saffar AS (2003) Mineral trioxide aggregate (MTA) and calcium hydroxide as pulp-capping agents in human teeth: a preliminary report. Int Endod J 36(3):225–231CrossRefPubMed
27.
Ooms EM, Egglezos EA, Wolke JG, Jansen JA (2003) Soft-tissue response to injectable calcium phosphate cements. Biomaterials 24(5):749–757CrossRefPubMed
28.
Keskinruzgar A, Bozdag Z, Aras MH, Demir T, Yolcu U, Cetiner S (2016) histopathological effects of teriparatide in medication-related osteonecrosis of the jaw: an animal study. J Oral Maxillofac Surg 74(1):68–78CrossRefPubMed
29.
Ikebe T (2013) Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw. Oral Sci Int 10(1):1–8CrossRef
30.
Yu W, Su J (2020) The effects of different doses of teriparatide on bisphosphonate-related osteonecrosis of the jaw in mice. Oral Dis 26(3):609–620CrossRefPubMed
31.
Zandi M, Dehghan A, Amini P, Doulati S, Rezaeian L (2019) Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw. Clin Oral Investig 23(11):3987–3993CrossRefPubMed
32.
Kajii F, Iwai A, Tanaka H, Matsui K, Kawai T, Kamakura S (2018) Single-dose local administration of teriparatide with a octacalcium phosphate collagen composite enhances bone regeneration in a rodent critical-sized calvarial defect. J Biomed Mater Res B Appl Biomater 106(5):1851–1857CrossRefPubMed
33.
Auersvald CM, Santos FR, Nakano MM, Leoni GB, de Sousa Neto MD, Scariot R et al (2017) The local administration of parathyroid hormone encourages the healing of bone defects in the rat calvaria: micro-computed tomography, histological and histomorphometric evaluation. Arch Oral Biol 79:14–19CrossRefPubMed
34.
Ersan N, van Ruijven LJ, Bronckers AL, Olgac V, Ilguy D, Everts V (2014) Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model. Dentomaxillofac Radiol 43(1):20130144CrossRefPubMed
35.
Thuruthel MJ, Surej Kumar LK, Kurien NM, Tharakan M (2023) Efficacy of gelatamp in controlling the postoperative sequelae following mandibular posterior teeth extraction—a split-mouth study. J Oral Biol Craniofac Res 13(2):96–103CrossRefPubMed
36.
Frost ML, Siddique M, Blake GM, Moore AE, Schleyer PJ, Dunn JT et al (2011) Differential effects of teriparatide on regional bone formation using (18)F-fluoride positron emission tomography. J Bone Miner Res 26(5):1002–1011CrossRefPubMed
Metadaten
Titel
Local Single-Dose Teriparatide Administration for BRONJ Prevention: Insights from a Rat Model Study
verfasst von
Milad Etemadi Sh
Farshad Teimoori
MohammadSoroush Sehat
Seyed Mohammad Razavi
Golnaz Tajmiri
Publikationsdatum
05.09.2024
Verlag
Springer India
Erschienen in
Journal of Maxillofacial and Oral Surgery
Print ISSN: 0972-8279
Elektronische ISSN: 0974-942X
DOI
https://doi.org/10.1007/s12663-024-02301-6

Neu im Fachgebiet Chirurgie

Unterarmfraktur: Tipps für ein zielgerichtetes Vorgehen

Bei Verdacht auf eine Unterarmfraktur seien 1000 Entscheidungen in 15 Minuten zu treffen, so der Kinderchirurg Dr. Stephan Rohleder auf dem Kongress für Kinder- und Jugendmedizin. Seine Tipps für ein zielgerichtetes Vorgehen erleichtern die adäquate Versorgung.

Wenige Komplikationen nach Mesh-verstärktem Bauchdeckenverschluss

Langzeitdaten der PRIMA-Studie sprechen dafür, dass das Komplikationsrisiko von Mesh-Implantaten bei bauchoperierten Personen mit hohem Risiko für Narbenhernien niedrig ist.

Auch vor viszeralchirurgischen Eingriffen auf den Zahnstatus achten!

Schlechte Zähne erhöhen das Risiko postoperativer Infektionen. Das gilt, wie eine aktuelle Studie aus der Uniklinik Heidelberg nahelegt, speziell auch für viszeralchirurgische Eingriffe.

Weltweit erste Transplantation eines kompletten Auges – erste Verlaufsdaten

Das weltweit bisher einzige Ärzteteam, das ein vollständiges Auge transplantiert hat, hat jetzt erstmals Vorgehen und Resultate umfangreich für die Fachwelt beschrieben – mit interessanten Einsichten.  

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise